首页> 外国专利> Novel Hyaluronan-Binding Proteins and Encoding Genes

Novel Hyaluronan-Binding Proteins and Encoding Genes

机译:新型透明质酸结合蛋白和编码基因

摘要

The present invention relates to full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP, novel members of the hyaluronan receptor family. The invention provides isolated nucleic acid molecules encoding human to full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP receptors. Full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP polypeptides are also provided, as are vectors, host cells and recombinant methods for producing the same. The invention further relates to screening methods for identifying agonists and antagonists of full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP receptor activity. Also provided are diagnostic methods for detecting disease states related to the aberrant expression of full-length WF-HABP, WF-HABP, OE-HABP, and BM-HABP receptors. Further provided are therapeutic methods for treating disease states including, but not limited to, proliferative conditions, metastasis, inflammation, ischemia, host defense dysfunction, immune surveillance dysfunction, arthritis, multiple sclerosis, autoimmunity, immune dysfunction, and allergy.
机译:本发明涉及透明质酸受体家族的新型成员全长WF-HABP,WF-HABP,OE-HABP和BM-HABP。本发明提供了分离的核酸分子,其编码人至全长的WF-HABP,WF-HABP,OE-HABP和BM-HABP受体。还提供了全长WF-HABP,WF-HABP,OE-HABP和BM-HABP多肽,以及载体,宿主细胞和产生它们的重组方法。本发明进一步涉及用于鉴定全长WF-HABP,WF-HABP,OE-HABP和BM-HABP受体活性的激动剂和拮抗剂的筛选方法。还提供了用于检测与全长WF-HABP,WF-HABP,OE-HABP和BM-HABP受体异常表达有关的疾病状态的诊断方法。还提供了用于治疗疾病状态的治疗方法,所述疾病包括但不限于增殖性疾病,转移,炎症,局部缺血,宿主防御功能障碍,免疫监视功能障碍,关节炎,多发性硬化症,自身免疫,免疫功能障碍和过敏。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号